Bioorganic & Medicinal Chemistry

Papers
(The TQCC of Bioorganic & Medicinal Chemistry is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Synthesis and antiproliferative activity of (−)-cleistenolide, (6S)-cleistenolide and 4-substituted cleistenolide analogues127
Current Japanese pharmaceutical chemistry115
Targeting prolidase. A survey of the literature data to depict a structure-activity relationship frame and to address future studies for drug development87
Sulfadoxine derivatization through multicomponent reactions to obtain new antiplasmodial compounds71
Innovative synthesis and purification method of fluorescent and bifunctional substrates for self-labelling protein tags71
Diterpenoids from the whole plants of Croton yunnanensis and their bioactivities44
Targeting m6A binding protein YTHDFs for cancer therapy42
Site-specific construction of triptolide-based antibody-drug conjugates42
Sustainable electrochemical C(sp3) − H oxygenation using water as the oxygen source41
Development of delivery carriers for plasmid DNA by conjugation of a helical template to oligoarginine40
Synthesis and medicinal chemistry of tetronamides: Promising agrochemicals and antitumoral compounds39
Graphical abstract TOC37
Synthesis and biological evaluation of pyrazole-fused oleanolic acid derivatives as novel inhibitors of inflammatory and osteoclast differentiation37
Graphical abstract TOC36
RNA-templated chemical synthesis of proapoptotic L- and d-peptides35
Contents continued34
Design, synthesis and validation of a new Crimped Head-Piece for DNA-Encoded libraries generation34
Production and synthesis of a novel 191Pt-labeled platinum complex and evaluation of its biodistribution in healthy mice33
Research progress of STAT3-based dual inhibitors for cancer therapy32
Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors32
A DNA-encoded library special issue30
Design, synthesis and antibacterial evaluation of oxazolidinone derivatives containing N-methylglycyl or quaternary ammonium salts30
Crescent-shaped meta-substituted benzene derivatives as a new class of non-nucleoside ribonuclease A inhibitors30
Editorial Board30
Discovery of trisubstituted meta-carboranes as T cell activators by regulating CD28 cytoplasmic region and SH2 domains of Grb2 and PI3K interactions29
Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents28
Design, synthesis and evaluation the bioactivities of novel 1,3-dimethyl-6-amino-1H-indazole derivatives as anticancer agents28
Discovery of 3-hydroxymethyl-azetidine derivatives as potent polymerase theta inhibitors27
Multiple approaches to repurposing drugs for neuroblastoma26
Janus dendritic ionizable lipids with fine designed headgroup and tails to improve mRNA delivery efficiency26
Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis26
Exploring novel A2AAR antagonists: Design, synthesis, and evaluation of 2,6,9-trisubstituted purine derivatives as promising antifibrotic agents26
Peptide-based CE-SELEX enables convenient isolation of aptamers specifically recognizing CD20-expressing cells25
Design, synthesis, and antiviral activity of 1-aryl-4-arylmethylpiperazine derivatives as Zika virus inhibitors with broad antiviral spectrum25
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling25
Graphical abstract TOC25
Graphical abstract TOC25
Editorial Board24
Synthesis, evaluation of anti-breast cancer activity in vitro of ICS II derivatives and summary of the structure-activity relationship24
Corrigendum to “Discovery of 1,3,4-oxadiazole derivatives as potential antitumor agents inhibiting the programmed cell death-1/programmed cell death-ligand 1 interaction” [Bioorg. Med. Chem. 46 (2021)23
A pharmacophore-based approach to demonstrating the scope of alcohol dehydrogenases23
Oligonucleotides containing 2′-O-methyl-5-(1-phenyl-1,2,3-triazol-4-yl)uridines demonstrate increased affinity for RNA and induce exon-skipping in vitro23
Contents continued22
Design, synthesis, and analgesia evaluation of novel Transient Receptor Potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)22
Graphical abstract TOC22
More than forty years of nucleic acid structural science21
Design, synthesis and biological evaluation of novel indole derivatives as gut-selective NaPi2b inhibitors21
Graphical abstract TOC21
Editorial Board21
Design and evaluation of novel analogs of 2-amino-4-boronobutanoic acid (ABBA) as inhibitors of human gamma-glutamyl transpeptidase21
Current development and structure–activity relationship study of berberine derivatives20
Graphical abstract TOC20
Graphical abstract TOC20
CRBN ligand expansion for hematopoietic prostaglandin D2 synthase (H-PGDS) targeting PROTAC design and their in vitro ADME profiles20
Pentacyclic triterpene-amino acid derivatives induced apoptosis and autophagy in tumor cells, affected the JNK and PI3K/AKT/mTOR pathway20
Development of novel quinoline-NO donor hybrids inducing human breast cancer cells apoptosis via inhibition of topoisomerase I20
1,3-Disubstituted-1,2,4-triazin-6-ones with potent activity against androgen receptor-dependent prostate cancer cells20
Discovery of tetracyclic 1,2,4-triazoline-fused dibenzo[b,f][1,4]oxazepine as a potent anti-colorectal cancer agent with good efficacy and low toxicity20
Chemical similarities and differences among inhibitors of nitric oxide synthase, arginase and dimethylarginine dimethylaminohydrolase-1: Implications for the design of novel enzyme inhibitors modulati20
Assessing the rigidity of cubanes and bicyclo(1.1.1)pentanes as benzene bioisosteres20
Investigation on the solid-phase synthesis of silybin prodrugs and their timed-release19
Concise synthesis of piperarborenine B19
Design and evaluation of achiral, non-atropisomeric 4-(aminomethyl)phthalazin-1(2H)-one derivatives as novel PRMT5/MTA inhibitors19
Graphical Abstract Contents Continued19
Combining CuAAC reaction enables sialylated Bi- and triantennary pseudo mannose N-glycans for investigating Siglec-7 interactions19
Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents18
Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease18
Fatty acid binding protein 5 inhibitors as novel anticancer agents against metastatic castration-resistant prostate cancer18
Structure activity relationship and target prediction for ABX464 analogues in Caenorhabditis elegans18
Synthesis and biological evaluation of O4′-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents18
Design, Synthesis, and biological evaluation of 7H-Pyrrolo[2,3-d]pyrimidines as potent HPK1 kinase inhibitors18
Structural optimization of naturally derived Ar-turmerone, as novel neuroinflammation suppressors effective in an Alzheimer mouse model18
Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants17
Structure-activity relationships of middle-size cyclic peptides, KRAS inhibitors derived from an mRNA display17
Directly arylated oligonucleotides as fluorescent molecular rotors for probing DNA single-nucleotide polymorphisms17
Ligand- and structure-based identification of novel CDK9 inhibitors for the potential treatment of leukemia17
The 2022 Monkeypox outbreak: How the medicinal chemistry could help us?17
Inhibition of cytochrome bd oxidase in Mycobacterium tuberculosis by benzothiazole amides17
Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia17
Synthesis and mammalian cell compatibility of light-released glycan precursors for controlled metabolic engineering17
Di-indenopyridines as topoisomerase II-selective anticancer agents: Design, synthesis, and structure–activity relationships17
Editorial Board17
Graphical abstract TOC17
Small phenolic inhibitors of PfATP6, a Plasmodium falciparum calcium ATPase, as prototype antimalarials17
Neopetrosidines A–D, pyridine alkaloids isolated from the marine sponge Neopetrosia chaliniformis and their cell cycle elongation activity17
Editorial Board17
Discovery of pyrazolo[3,4-d]pyrimidines as novel mitogen-activated protein kinase kinase 3 (MKK3) inhibitors17
In Vivo Imaging of Tumor Hypoxia by Maintaining Green Fluorescence of 9-Aminoanthracene Under Hypoxic Conditions17
A turn for the worse: Aβ β-hairpins in Alzheimer’s disease16
Dihydroartemisinin improves hypercholesterolemia in ovariectomized mice via enhancing vectorial transport of cholesterol and bile acids from blood to bile16
Design, synthesis and biological evaluation of phosphoroxy quinazoline derivatives as potential EGFRT790M/C797S inhibitors16
Hetero-aryl bromide precursor fluorine-18 radiosynthesis and preclinical evaluation of a novel positron emission tomography (PET) tracer [18F]GSK148216016
Two distinct rotations of bithiazole DNA intercalation revealed by direct comparison of crystal structures of Co(III)•bleomycin A2 and B2 bound to duplex 5′-TAGTT sites16
4-Arylidene curcumin derivatives in vitro inhibit α-Synuclein aggregation and disaggregate the preformed fibril16
Design and identification of brain-penetrant, potent, and selective 1,3-oxazole-based cholesterol 24-hydroxylase (CH24H) inhibitors16
Introduction of a carboxylic acid group into pyrazolylpyridine derivatives increased selectivity for inhibition of the 20-HETE synthase CYP4A11/4F216
Discovery of SYD5115, a novel orally active small molecule TSH-R antagonist16
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for 16
Graphical abstract TOC16
3-Amino-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carbonitrile: A fluorescent molecule that induces differentiation in PC12 cells16
The design of protozoan phosphoribosyltransferase inhibitors containing non-charged phosphate mimic residues16
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction15
Design, synthesis and biological evaluation of EGFR kinase inhibitors that spans the orthosteric and allosteric sites15
Graphical abstract TOC15
Design, synthesis and in vitro validation of bivalent binders of SARS-CoV-2 spike protein: Obeticholic, betulinic and glycyrrhetinic acids as building blocks15
Design and synthesis of phenanthridinone and phenanthridine derivatives and their radiosensitizing activity15
In vivo imaging of fluorescent albumin modified with pyruvylated-human-type complex oligosaccharide reveals sialylation-like biodistribution and kinetics15
Graphical abstract TOC15
Scaffold hopping and sidechain modification from a flavone scaffold lead to discovery of potent, selective CK2A2 inhibitors with favorable properties for CNS activity15
Modulation of aryl hydrocarbon receptor activity by halogenated indoles15
Cytotoxicity of cinchona alkaloid organocatalysts against MES-SA and MES-SA/Dx5 multidrug-resistant uterine sarcoma cell lines15
A TNF-α blocking peptide that reduces NF-κB and MAPK activity for attenuating inflammation15
Editorial Board15
Discovery of a potent C20-oxime pachysandra alkaloid analogue promising for treatment of hepatocellular carcinoma15
Discovery of structurally diverse diazatricyclododecenes as lysosomotropic autophagy inhibitors15
Generation of an RNA aptamer against LipL32 of Leptospira isolated by Tripartite-hybrid SELEX coupled with in-house Python-aided unbiased data sorting14
Structure-activity relationships of 2-pyrimidinecarbohydrazides as utrophin modulators for the potential treatment of Duchenne muscular dystrophy14
Discovery of polymethoxyphenyl-pyridines bearing amino side chains as tubulin colchicine-binding site inhibitors14
Synthesis and biological evaluation of indoline derivatives as CDGSH iron sulfur domain 2 activators14
Discovery and optimization of orally bioavailable and potent plasma Kallikrein inhibitors bearing a quaternary carbon14
Synthesis and antibacterial properties under blue LED light of conjugates between the siderophore desferrioxamine B (DFOB) and an Iridium(III) complex14
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters14
Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease14
Discovery and structure-activity relationship of Morita-Baylis-Hillman adducts as larvicides against dengue mosquito vector, Aedes aegypti (Diptera: Culicidae)14
Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA14
Fluorescent probes and degraders of the sterol transport protein Aster-A14
From natural products to HDAC inhibitors: An overview of drug discovery and design strategy14
Recent advances on synthesis and biological activities of C-17 aza-heterocycle derived steroids14
Exploring novel pyrazole-nitroimidazole hybrids: Synthesis and antiprotozoal activity against the human pathogen trichomonas vaginalis14
Chemical design of radioiodinated probes with a metabolizable linkage for target-selective imaging of systemic amyloidosis14
Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors14
Identification of novel influenza polymerase PB2 inhibitors using virtual screening approach and molecular dynamics simulation analysis of active compounds14
Exploring the interaction of N-(benzothiazol-2-yl)pyrrolamide DNA gyrase inhibitors with the GyrB ATP-binding site lipophilic floor: A medicinal chemistry and QTAIM study14
Contents continued13
Truxillic acid monoamides as fatty acid binding protein 5 inhibitors13
Graphical abstract TOC13
Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer13
Graphical Abstract TOC13
FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I13
Editorial Board13
Phenotypic screen identifies FOXO inhibitor to counteract maturation and promote expansion of human iPS cell-derived cardiomyocytes13
Synthesis, biological activity and mechanism of action of novel allosecurinine derivatives as potential antitumor agents13
An insight into the mechanistic role of (-)-Ampelopsin F from Vatica chinensis L. in inducing insulin secretion in pancreatic beta cells13
In vitro activity of N-phenyl-1,10-phenanthroline-2-amines against tachyzoites and bradyzoites of Toxoplasma gondii13
Graphical abstract TOC13
Synthetic studies on the extracellular domain of the T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) using Trt-K10 solubilizing tags13
Editorial Board12
Synthesis and characterization of new acid-functionalized porphyrins displaying antimicrobial activity against gram positive bacteria, yeasts and filamentous fungi with or without ultra-high irradianc12
Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction12
Stereoisomers of cannabidiols and their pharmacological activities – A potentially novel direction for cannabinoids12
Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives12
Influence of N-arylsulfonamido d-valine N-substituents on the selectivity and potency of matrix metalloproteinase inhibitors12
Rational design of AIEgens through π-bridge engineering for dual-modal photodynamic and photothermal therapy12
Discovery and optimization of anthraquinone derivatives containing substituted bisbenzyloxy groups as a novel scaffold damaged endoplasmic reticulum and against hepatocellular carcinoma cells12
Design of a potent and selective dual JAK1/TYK2 inhibitor12
Synthesis and biological evaluation of novel isobenzofuran-1(3H)-one derivatives as antidepressant agents12
Growth factors and their peptide mimetics for treatment of traumatic brain injury12
Corrigendum to “Discovery of novel Quinazoline-based KRAS G12C inhibitors as potential anticancer agents” [Bioorg. Med. Chem. 71 (2022) 116962]12
Editorial Board12
Structure-based design of a novel series of cholesterol 24-hydroxylase (CH24H) inhibitors bearing 1,3-oxazole as a heme–iron binding group12
Editorial Board12
PET imaging of VEGFR and integrins in glioma tumor xenografts using 89Zr labelled heterodimeric peptide12
Recent research progress of β-carbolines as privileged scaffold in the discovery of anticancer agent (2019–2024)12
Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice12
Synthesis and biophysical properties of tetravalent PEG-conjugated antisense oligonucleotide11
Synthesis of 6-ethoxyphenyl 4-fluorobenzenesulfonate-tagged thiosemicarbazones as carbonic anhydrase inhibitors: In-vitro and in silico approach11
Structure-based screening combined with computational and biochemical analyses identified the inhibitor targeting the binding of DNA Ligase 1 to UHRF111
Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways11
Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathway11
Selenoneine-inspired selenohydantoins with glutathione peroxidase-like activity11
Structure-based lead optimization to improve potency and selectivity of a novel tetrahydroimidazo[1,2-a]pyridine-5-carboxylic acid series of heparanase-1 inhibitor11
Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP+) as a carrier11
Structure-activity relationship studies and biological properties evaluation of peptidic NRP-1 ligands: Investigation of N-terminal cysteine importance11
Graphical abstract TOC11
Effect of phenylurea hydroxamic acids on histone deacetylase and VEGFR-211
An assessment of the mutational load caused by various reactions used in DNA encoded libraries11
Editorial Board11
Design, synthesis, and biological evaluation of 2-arylamino-4-(piperidin-4-yloxy)pyrimidines as potent EGFRT790M/L858R inhibitors to treat non-small cell lung cancer11
Editorial Board11
The most common linkers in bioactive molecules and their bioisosteric replacement network11
Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase11
Next generation Glucose-1-phosphate thymidylyltransferase (RmlA) inhibitors: An extended SAR study to direct future design11
Potential COX-2 inhibitors modulating NF-κB/MAPK signaling pathways: Design, synthesis and evaluation of anti-inflammatory activity of Pterostilbene-carboxylic acid derivatives with an oxime ether moi11
Graphical abstract TOC11
Synthesis and biological evaluation of 4H-benzo[e][1,3]oxazin-4-ones analogues of TGX-221 as inhibitors of PI3Kβ10
Engineered B7-H3-targeted VHH-Fc fusion antibody demonstrates rapid tumor accumulation for infrared imaging in pancreatic cancer xenograft model10
Discovery of evodiamine derivatives as potent insecticide candidates10
Elongation of N6-benzyladenosine scaffold via Pd-catalyzed C–C bond formation leads to derivatives with antiflaviviral activity10
Target discovery of bioactive natural products with native-compound-coupled CNBr-activated Sepharose 4B beads (NCCB): Applications, mechanisms and outlooks10
Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca2+ channel blockers10
Design, synthesis, and pharmacological evaluation of N-(3-carbamoyl-1H-pyrazol-4-yl)-1,3-oxazole-4-carboxamide derivatives as interleukin-1 receptor-associated kinase 4 inhibitors with reduced potenti10
Design, synthesis and biological evaluation of 3-arylisoquinoline derivatives as topoisomerase IIα inhibitors for the therapy of small cell lung cancer10
Dual-responsive drug release and fluorescence imaging based on disulfide-pillar[4]arene aggregate in cancer cells10
Discovery and biological evaluation of novel dual PTP1B and ACP1 inhibitors for the treatment of insulin resistance10
Graphical abstract TOC10
Graphical abstract TOC10
Discovery and development of small-molecule heparanase inhibitors10
Saturation transfer difference (STD)-NMR spectroscopy in drug discovery: A comprehensive review on identified potential hits based on natural and synthetic scaffolds against therapeutic drug targets10
Design, synthesis and anti-tumor efficacy of novel phenyl thiazole/triazole derivatives as selective TrkA inhibitors10
Biocompatible conjugated polymer nanoparticles labeled with 225Ac for tumor endoradiotherapy10
Effect of helicity and hydrophobicity on cell-penetrating ability of arginine-rich peptides10
Glutathione-responsive PROTAC for targeted degradation of ERα in breast cancer cells9
Symmetric bis-benzimidazoles as DNA minor groove-binding agents with anti-tumour and antibacterial activity, and the evolution of the drug ridinilazole for the treatment of Clostridium difficile infec9
Screening and evaluation of hydrophobic cell-penetrating peptides for antisense oligonucleotide delivery9
Harnessing polyhydroxylated pyrrolidines as a stabilizer of acid alpha-glucosidase (GAA) to enhance the efficacy of enzyme replacement therapy in Pompe disease9
Editorial Board9
Synthesis of sp3-rich chiral bicyclo[3.3.1]nonanes for chemical space expansion and study of biological activities9
Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin9
Design and synthesis of sulfonamides incorporating a biotin moiety: Carbonic anhydrase inhibitory effects, antiproliferative activity and molecular modeling studies9
Recent applications of seven-membered rings in drug design9
Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents9
Suramin analogues protect cartilage against osteoarthritic breakdown by increasing levels of tissue inhibitor of metalloproteinases 3 (TIMP-3) in the tissue9
A special issue on artificial intelligence for drug discovery9
Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease9
Drug discovery targeting protein arginine methyltransferase 5 (PRMT5): an update9
Design, classification, and adverse effects of NSAIDs: A review on recent advancements9
Advances in the development of Rho GTPase inhibitors9
Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors9
The application of PROTACs in immune-inflammation diseases9
Design, synthesis and anti-rheumatoid arthritis activity of target TLR4 inhibitors9
Graphical Abstract TOC9
Graphical abstract TOC9
Graphical abstract TOC9
Structure activity relationships leading to the identification of the indirect activator of AMPK, R4199
Editorial Board9
Synthesis and biological evaluation of sulfonylpyridine derivatives as potential anti-chlamydia agents9
Discovery of novel 3-butyl-6-benzyloxyphthalide Mannich base derivatives as multifunctional agents against Alzheimer's disease9
Design, synthesis, and biological evaluation of a potential long-acting glucagon-like peptide-1 (GLP-1) analog9
The natural anthraquinone dye purpurin exerts antibacterial activity by perturbing the FtsZ assembly9
RAD18-catalysed formation of ubiquitination intermediate mimic of proliferating cell nuclear antigen PCNA9
Discovery of pyrido[4,3-d]pyrimidinone derivatives as novel Wee1 inhibitors9
Discovery of acetohydroxyacid synthase inhibitors as anti-tuberculosis lead compounds from natural products9
Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors9
Synthesis and structural optimization of oncolytic peptide LTX-3159
Editorial Board9
Discovery, Topo I inhibitory activity and mechanism evaluation of two novel cytisine-type alkaloid dimers from the seeds of Sophora alopecuroides L9
Editorial Board9
Graphical abstract TOC9
Contents continued9
Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding Activity9
Identification of potent α-amylase inhibitors via dynamic combinatorial chemistry9
New phenylpiperazine-thiazolidine-2,4-dione hybrids targeting MAO inhibition: Synthesis, biological evaluation, kinetic study and in silico insights9
Synthesis and antimicrobial studies of cadasides analogues via on-resin esterification9
Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to red9
A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing9
Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential9
Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents9
Design, synthesis, and bioactivity study on Lissodendrins B derivatives as PARP1 inhibitor9
Recent achievements in molecular insights, anticancer activities, and comparative structure activity relationships of thiazolidin-4-one derivatives as EGFR inhibitors (2019-present)8
Polyguluronate simulations shed light onto the therapeutic action of OligoG CF-5/208
0.11603093147278